[Summary] The IRIC Virtual Symposium : “GPCRs In Oncology & Immuno-oncology” – Sponsored by Domain Therapeutics

On june 4, Domain Therapeutics the pleasure to sponsor the IRIC Virtual Symposium.

Chaired by Professor Michel Bouvier, CEO of IRIC and esteemed chairman of Domain Therapeutics SAB, this symposium highlights some of the most recent discoveries and techniques to address GPCR potential in oncology and immuno-oncology.

Leading experts, such as Domain Therapeutics CSO Xavier Leroy, shared the results of world-class academic and private research on GPCRs in these crucial fields.


You didn’t get a chance to attend this exciting event ?

We are pleased to provide you with an article summarizing this exciting discussions